Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Nelonemdaz safe but fails to improve outcomes in stroke
Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.
Nelonemdaz safe but fails to improve outcomes in stroke
01 Nov 2022Psychotic disorders a potentially modifiable risk factor for dementia
Individuals with nonaffective psychotic disorders appear to have a twofold higher risk of developing subsequent dementia compared with those who do not have such disorders, as reported in a recent study.
Psychotic disorders a potentially modifiable risk factor for dementia
25 Oct 2022Early noninferior to delayed NOAC initiation after stroke in AF patients
Early initiation of nonvitamin K antagonist oral anticoagulants (NOACs) after acute ischaemic stroke in patients with atrial fibrillation (AF) appears to yield similar outcomes when compared with delayed initiation, as shown in the results of the TIMING* study.